Correction: Lee et al. Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors. Cancers 2022, 14, 2659
Reference
- Lee, J.H.; Shin, S.-J.; Choe, E.-A.; Kim, J.; Hyung, W.J.; Kim, H.S.; Jung, M.; Beom, S.-H.; Kim, T.I.; Ahn, J.B.; et al. Tropomyosin-related kinase fusions in gastrointestinal stromal tumors. Cancers 2022, 14, 2659. [Google Scholar] [CrossRef] [PubMed]
Characteristics | Total (n = 31) N (%) | NTRK Fusion (n = 5) | NTRK Wild Type (n = 26) | p-Value |
---|---|---|---|---|
Age | ||||
Median (range) | 56 (33–92) | 61 (33–92) | 53 (37–84) | 0.163 |
Sex | - | - | - | 1000 |
Male | 14 (45.2) | 2 (40.0) | 12 (46.2) | - |
Female | 17 (54.8) | 3 (60.0) | 14 (53.8) | - |
Tumor size (cm) | - | - | - | - |
Median ± SD | 8.2 ± 5.3 | 3.9 ± 6.5 | 6.0 ± 5.2 | 0.410 |
Tumor location | - | - | - | 0.028 |
Abdominal wall | 1 (0.3) | 0 (0.0) | 1 (3.8) | - |
Stomach | 14 (45.1) | 1 (20.0) | 14 (53.8) | - |
Small bowel | 11 (35.4) | 2 (40.0) | 6 (23.1) | - |
Descending colon | 1 (0.3) | 0 (0.0) | 1 (3.8) | - |
Rectum | 4 (12.9) | 2 (40.0) | 4 (15.4) | - |
Tumor size, groups (cm) ◇ | - | - | - | 1000 |
≤5 | 14 (50.0) | 3 (60.0) | 11 (47.8) | - |
>5 | 14 (50.0) | 2 (40.0) | 12 (52.2) | -- |
Mitotic rate ◐ (no. of mitoses/50 HPFs *) | - | - | - | 0.711 |
≤5 | 11 (50.0) | 2 (40.0) | 12 (52.2) | - |
>5 | 16 (50.0) | 3 (60.0) | 10 (43.5) | - |
Disease status | - | - | - | 0.859 |
No evidence of disease | 21 (67.7) | 5 (100.0) | 16 (61.5) | - |
on anticancer treatment | 3 (9.7) | 0 (0.0) | 3 (11.5) | - |
Unknown | 3 (9.7) | 0 (0.0) | 3 (11.5) | - |
Dead | 4 (12.9) | 0 (0.0) | 4 (15.4) | - |
Risk of metastasis ◈ | - | - | - | 0.253 |
Low | 8 (25.8) | 1 (20.0) | 7 (26.9) | - |
Intermediate | 3 (9.7) | 0 (0.0) | 3 (11.5) | - |
High | 17 (54.8) | 4 (80.0) | 13 (50.0) | - |
Not assessable | 3 (9.7) | 0 (0.0) | 3 (11.5) | - |
Surgical treatment | - | - | - | 1000 |
Yes | 28 (90.3) | 5 (100.0) | 23 (88.5) | - |
No | 3 (9.7) | 0 (0.0) | 3 (11.5) | - |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lee, J.H.; Shin, S.-J.; Choe, E.-A.; Kim, J.; Hyung, W.J.; Kim, H.S.; Jung, M.; Beom, S.-H.; Kim, T.I.; Ahn, J.B.; et al. Correction: Lee et al. Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors. Cancers 2022, 14, 2659. Cancers 2022, 14, 5658. https://doi.org/10.3390/cancers14225658
Lee JH, Shin S-J, Choe E-A, Kim J, Hyung WJ, Kim HS, Jung M, Beom S-H, Kim TI, Ahn JB, et al. Correction: Lee et al. Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors. Cancers 2022, 14, 2659. Cancers. 2022; 14(22):5658. https://doi.org/10.3390/cancers14225658
Chicago/Turabian StyleLee, Ji Hyun, Su-Jin Shin, Eun-Ah Choe, Jungyoun Kim, Woo Jin Hyung, Hyo Song Kim, Minkyu Jung, Seung-Hoon Beom, Tae Il Kim, Joong Bae Ahn, and et al. 2022. "Correction: Lee et al. Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors. Cancers 2022, 14, 2659" Cancers 14, no. 22: 5658. https://doi.org/10.3390/cancers14225658
APA StyleLee, J. H., Shin, S. -J., Choe, E. -A., Kim, J., Hyung, W. J., Kim, H. S., Jung, M., Beom, S. -H., Kim, T. I., Ahn, J. B., Chung, H. C., & Shin, S. J. (2022). Correction: Lee et al. Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors. Cancers 2022, 14, 2659. Cancers, 14(22), 5658. https://doi.org/10.3390/cancers14225658